Sensitivity analysis
Effect . | Reference . | OR (95% CI) . | P value . |
---|---|---|---|
Full model | |||
Anatomic venous abnormality, yes | No | 2.9 (1.27-6.50) | .011 |
IBD, yes | No | 2.84 (0.95-8.47) | .061 |
IF, yes | No | 1.79 (0.60-5.38) | .300 |
CVC, yes | No | 1.5 (0.80-2.75) | .217 |
Congenital thrombophilia, no | Yes | 1.6 (0.65-4.00) | .307 |
Hospital at the time of first thrombosis, in | Out | 1.7 (0.86-3.31) | .126 |
Reduced model | |||
CVC, yes | No | 2.0 (1.14-3.51) | .015 |
Anatomic venous abnormality, yes | No | 2.3 (1.09-5.02) | .029 |
IBD, yes | No | 2.64 (0.90-7.76) | .077 |
Effect . | Reference . | OR (95% CI) . | P value . |
---|---|---|---|
Full model | |||
Anatomic venous abnormality, yes | No | 2.9 (1.27-6.50) | .011 |
IBD, yes | No | 2.84 (0.95-8.47) | .061 |
IF, yes | No | 1.79 (0.60-5.38) | .300 |
CVC, yes | No | 1.5 (0.80-2.75) | .217 |
Congenital thrombophilia, no | Yes | 1.6 (0.65-4.00) | .307 |
Hospital at the time of first thrombosis, in | Out | 1.7 (0.86-3.31) | .126 |
Reduced model | |||
CVC, yes | No | 2.0 (1.14-3.51) | .015 |
Anatomic venous abnormality, yes | No | 2.3 (1.09-5.02) | .029 |
IBD, yes | No | 2.64 (0.90-7.76) | .077 |
Results from logistic regression analyses, modeling odds of a repeat VTE; now only for those patients whose first VTE occurred on or after 1 January 2015 (n = 584). Initial predictors (full model) were included based on univariate results. Final model includes only significant predictors after using backward elimination.
CI, confidence interval; OR, odds ratio.